Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2014; 20(1): 163-174
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.163
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.163
Table 4 The partial least-squares-discriminant analysis models obtained from proton nuclear magnetic resonance-based analysis of urine samples
Comparison | Model | P value | Q2 (cum) | Number of latent variables |
CD vs UC | PLS-DA | 0.388 | 0.1 | 2 |
CD active vs UC active | PLS-DA | 1.000 | -0.2 | 2 |
IBD active vs control | PLS-DA | 0.003 | 0.6 | 4 |
IBD remission vs control | PLS-DA | 0.037 | 0.31 | 2 |
IBD active vs IBD remission | PLS-DA | 0.003 | 0.38 | 3 |
- Citation: Dawiskiba T, Deja S, Mulak A, Ząbek A, Jawień E, Pawełka D, Banasik M, Mastalerz-Migas A, Balcerzak W, Kaliszewski K, Skóra J, Barć P, Korta K, Pormańczuk K, Szyber P, Litarski A, Młynarz P. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. World J Gastroenterol 2014; 20(1): 163-174
- URL: https://www.wjgnet.com/1007-9327/full/v20/i1/163.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i1.163